CELLAVISION AB (publ) Interim report for the period January 1 - March 31, 2008

Continued growth and establishment of subsidiary in Japan

*    Net sales for the quarter increased by 10% to SEK 18.5 million
  (16.8).
*    The operating result for the quarter was SEK 1.3 million (-1.0).
*    The net result per share for the period amounted to SEK 0.05
  (-0.05).
*    Liquid assets amounted to SEK 16.1 million (7.0) at the end of
  the quarter.
*    Subsidiary established in Japan. 
*   An Icelandic hospital has placed an order. CellaVision now has
  clients in all five Nordic countries.
 

  CellaVision in summary            
  (MSEK)           Q1 2008 Q1 2007 Full year 2007
               
  Net sales           18.5    16.8           74.6
  Gross profit        11.9     9.5           45.3
  Operating result     1.3    -1.0            3.1
  Net result           1.2    -1.1            2.6
  Cash flow           -0.3    -9.8           -0.4

 
 
CEO's comment"CellaVision's positive  trend  of  2007  continued  into  the  first
quarter of 2008. We can report sound sales growth and are  continuing
to strengthen our  position in the  market," says Yvonne  Mårtensson,
CEO of CellaVision. "A large American commercial laboratory chain has
purchased the CellaVision®  DM96 for 14  of their laboratories.  This
further validates CellaVision's belief  that our technology  delivers
significant cost  benefits to  the clinical  laboratory. To  use  the
positive momentum, we will now add more sales resources in the US."
 "Following our evaluation of the  Japanese market we have  registered
our own subsidiary  in Japan.  During the  year we  will develop  the
organisation in order for it to  be operative when all the  necessary
licenses have been  obtained. Thereafter  we will  begin focusing  on
sales  either  direct  or  parallel  to  national  distributors.  Our
increased market  activity level  may negatively  influence our  cash
balance at the end of the year."
 
Yvonne Mårtensson
CEO CellaVision AB
 
 
For more information please contact: 
Yvonne Mårtensson, CEO. Tel: +46 708 33 77 82, e-mail:
yvonne.martensson@cellavision.se 
Johan Wennerholm, CFO. Tel: +46 708 33 81 68, e-mail:
johan.wennerholm@cellavision.se
 
 
Download the report by pressing the link below.